Kenneth Dahl

Kenneth Dahl is a results-driven (Radio)chemist and Chemical Engineer with a solid foundation in drug discovery and chemical method development. They hold a Master of Science degree in Chemical Engineering and a Doctorate in Radiopharmaceutical Science, and have extensive experience leading R&D projects across various scientific fields, including labeling chemistry, medicinal chemistry, and neuroscience. Kenneth's professional journey includes roles as a PET Imaging Scientist and Associate Director at AstraZeneca, Research Fellow at both Massachusetts General Hospital and Harvard Medical School, and positions at Karolinska University Hospital and Sahlgrenska University Hospital, among others. They have also worked as a Development Chemist and Research Coordinator, and served as a Laboratory Assistant and Teacher at KTH Royal Institute of Technology.